Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Behavior Therapy | 12 | 2020 | 121 | 3.420 |
Why?
|
| Counseling | 12 | 2020 | 170 | 3.080 |
Why?
|
| Mass Screening | 13 | 2020 | 670 | 2.160 |
Why?
|
| Primary Health Care | 13 | 2020 | 693 | 1.920 |
Why?
|
| Advisory Committees | 7 | 2022 | 112 | 1.680 |
Why?
|
| Colorectal Neoplasms | 5 | 2020 | 635 | 1.270 |
Why?
|
| Cardiovascular Diseases | 6 | 2022 | 520 | 1.200 |
Why?
|
| Depression | 7 | 2019 | 479 | 1.150 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2020 | 53 | 1.110 |
Why?
|
| Depression, Postpartum | 2 | 2019 | 27 | 1.020 |
Why?
|
| Sexual Behavior | 2 | 2020 | 112 | 1.000 |
Why?
|
| Humans | 60 | 2022 | 16832 | 0.940 |
Why?
|
| Health Behavior | 5 | 2020 | 332 | 0.870 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 202 | 0.870 |
Why?
|
| Weight Loss | 3 | 2018 | 302 | 0.800 |
Why?
|
| United States | 18 | 2022 | 3858 | 0.800 |
Why?
|
| Suicide | 3 | 2013 | 114 | 0.770 |
Why?
|
| Feces | 3 | 2020 | 90 | 0.770 |
Why?
|
| Minerals | 1 | 2022 | 7 | 0.730 |
Why?
|
| Substance-Related Disorders | 4 | 2020 | 305 | 0.730 |
Why?
|
| Prescription Drugs | 2 | 2020 | 29 | 0.720 |
Why?
|
| Antidepressive Agents | 4 | 2019 | 140 | 0.710 |
Why?
|
| Anti-Obesity Agents | 3 | 2018 | 19 | 0.710 |
Why?
|
| Vitamins | 1 | 2022 | 56 | 0.700 |
Why?
|
| Adult | 28 | 2022 | 7255 | 0.640 |
Why?
|
| Health Education | 1 | 2020 | 79 | 0.610 |
Why?
|
| Alcohol Drinking | 2 | 2020 | 298 | 0.600 |
Why?
|
| Adolescent | 22 | 2020 | 3464 | 0.600 |
Why?
|
| Exercise | 3 | 2020 | 513 | 0.600 |
Why?
|
| Risk Reduction Behavior | 3 | 2020 | 97 | 0.590 |
Why?
|
| Health Risk Behaviors | 1 | 2018 | 5 | 0.570 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 162 | 0.570 |
Why?
|
| Obesity Management | 1 | 2018 | 4 | 0.560 |
Why?
|
| Alcohol-Related Disorders | 1 | 2018 | 36 | 0.550 |
Why?
|
| Preventive Health Services | 4 | 2021 | 142 | 0.530 |
Why?
|
| Female | 32 | 2020 | 12193 | 0.520 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 186 | 0.520 |
Why?
|
| Neoplasms | 1 | 2022 | 447 | 0.510 |
Why?
|
| Asthma | 11 | 2007 | 375 | 0.460 |
Why?
|
| Pediatric Obesity | 1 | 2017 | 101 | 0.450 |
Why?
|
| Male | 26 | 2020 | 9556 | 0.440 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 160 | 0.440 |
Why?
|
| Outcome Assessment (Health Care) | 2 | 2015 | 199 | 0.440 |
Why?
|
| Early Detection of Cancer | 2 | 2020 | 553 | 0.440 |
Why?
|
| Obesity | 3 | 2018 | 811 | 0.430 |
Why?
|
| Pregnancy | 7 | 2020 | 1555 | 0.360 |
Why?
|
| Psychotherapy | 4 | 2020 | 55 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 311 | 0.330 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2018 | 317 | 0.320 |
Why?
|
| Aspirin | 3 | 2016 | 61 | 0.320 |
Why?
|
| Primary Prevention | 2 | 2022 | 60 | 0.290 |
Why?
|
| Middle Aged | 18 | 2020 | 7515 | 0.280 |
Why?
|
| Stomach | 1 | 2008 | 4 | 0.270 |
Why?
|
| Laparoscopy | 1 | 2008 | 45 | 0.260 |
Why?
|
| Gastric Bypass | 1 | 2008 | 71 | 0.250 |
Why?
|
| Aged | 12 | 2020 | 5901 | 0.250 |
Why?
|
| Child | 8 | 2020 | 2433 | 0.250 |
Why?
|
| Risk Assessment | 6 | 2014 | 1047 | 0.250 |
Why?
|
| Young Adult | 3 | 2020 | 2456 | 0.250 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 122 | 0.240 |
Why?
|
| Incidence | 5 | 2020 | 1229 | 0.240 |
Why?
|
| Hypertension | 3 | 2020 | 475 | 0.220 |
Why?
|
| Overweight | 4 | 2017 | 262 | 0.220 |
Why?
|
| Surveys and Questionnaires | 8 | 2020 | 1204 | 0.220 |
Why?
|
| Age Factors | 3 | 2020 | 814 | 0.210 |
Why?
|
| Pre-Eclampsia | 2 | 2014 | 41 | 0.200 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1058 | 0.200 |
Why?
|
| Dietary Supplements | 2 | 2022 | 83 | 0.200 |
Why?
|
| Vitamin A | 1 | 2022 | 12 | 0.180 |
Why?
|
| beta Carotene | 1 | 2022 | 17 | 0.180 |
Why?
|
| Prospective Studies | 3 | 2020 | 1186 | 0.180 |
Why?
|
| Marijuana Abuse | 2 | 2020 | 33 | 0.180 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 291 | 0.180 |
Why?
|
| Quality of Life | 4 | 2007 | 477 | 0.180 |
Why?
|
| Racism | 1 | 2021 | 23 | 0.170 |
Why?
|
| Lactones | 3 | 2017 | 11 | 0.170 |
Why?
|
| Health Maintenance Organizations | 7 | 2005 | 358 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 39 | 0.170 |
Why?
|
| Risk Factors | 7 | 2019 | 3108 | 0.170 |
Why?
|
| Depressive Disorder, Major | 3 | 2009 | 95 | 0.160 |
Why?
|
| Narration | 1 | 2020 | 8 | 0.160 |
Why?
|
| Adolescent Health Services | 2 | 2001 | 36 | 0.160 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 103 | 0.160 |
Why?
|
| Colonoscopy | 2 | 2020 | 261 | 0.160 |
Why?
|
| Language | 1 | 2020 | 51 | 0.160 |
Why?
|
| Tobacco Use | 1 | 2020 | 12 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2021 | 145 | 0.160 |
Why?
|
| Substance Abuse Detection | 1 | 2020 | 16 | 0.160 |
Why?
|
| Dyslipidemias | 1 | 2020 | 57 | 0.160 |
Why?
|
| Immunochemistry | 1 | 2020 | 20 | 0.160 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 23 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 114 | 0.150 |
Why?
|
| Serotonin Uptake Inhibitors | 3 | 2009 | 45 | 0.150 |
Why?
|
| Postal Service | 1 | 2020 | 72 | 0.150 |
Why?
|
| Public Health | 1 | 2020 | 80 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 213 | 0.150 |
Why?
|
| Sertraline | 1 | 2019 | 2 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2017 | 925 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2020 | 569 | 0.140 |
Why?
|
| Medicare | 1 | 2020 | 188 | 0.140 |
Why?
|
| Medicaid | 1 | 2020 | 189 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 268 | 0.140 |
Why?
|
| Occult Blood | 2 | 2016 | 161 | 0.140 |
Why?
|
| Prognosis | 1 | 2020 | 568 | 0.140 |
Why?
|
| Managed Care Programs | 5 | 2007 | 275 | 0.130 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 2 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2019 | 147 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2020 | 995 | 0.130 |
Why?
|
| Child, Preschool | 4 | 2017 | 1430 | 0.130 |
Why?
|
| Review Literature as Topic | 1 | 2017 | 15 | 0.130 |
Why?
|
| Metformin | 1 | 2017 | 49 | 0.130 |
Why?
|
| Treatment Outcome | 7 | 2011 | 1098 | 0.130 |
Why?
|
| Internet | 3 | 2017 | 207 | 0.120 |
Why?
|
| Body Weight | 1 | 2017 | 197 | 0.120 |
Why?
|
| Remission Induction | 1 | 2016 | 22 | 0.120 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 17 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 45 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2015 | 3 | 0.110 |
Why?
|
| Microsatellite Instability | 1 | 2015 | 16 | 0.110 |
Why?
|
| Fluorouracil | 1 | 2015 | 11 | 0.110 |
Why?
|
| Adenoma | 1 | 2016 | 97 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 247 | 0.110 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 57 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2020 | 702 | 0.110 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 57 | 0.100 |
Why?
|
| Street Drugs | 1 | 2014 | 6 | 0.100 |
Why?
|
| Smoking Prevention | 1 | 2013 | 32 | 0.090 |
Why?
|
| Diet | 1 | 2014 | 349 | 0.090 |
Why?
|
| Depressive Disorder | 2 | 2005 | 177 | 0.090 |
Why?
|
| Suicidal Ideation | 1 | 2013 | 98 | 0.090 |
Why?
|
| Patient Compliance | 2 | 2006 | 262 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 677 | 0.090 |
Why?
|
| Child of Impaired Parents | 2 | 2002 | 27 | 0.090 |
Why?
|
| Smoking Cessation | 1 | 2013 | 140 | 0.090 |
Why?
|
| Time Factors | 3 | 2015 | 989 | 0.090 |
Why?
|
| Dementia | 1 | 2013 | 137 | 0.080 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2010 | 23 | 0.080 |
Why?
|
| Data Collection | 3 | 2017 | 223 | 0.080 |
Why?
|
| Accidental Falls | 1 | 2010 | 49 | 0.080 |
Why?
|
| Oregon | 6 | 2006 | 168 | 0.080 |
Why?
|
| Feedback | 1 | 2009 | 22 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2009 | 98 | 0.070 |
Why?
|
| Sex Counseling | 1 | 2008 | 2 | 0.070 |
Why?
|
| Telephone | 2 | 2006 | 157 | 0.070 |
Why?
|
| Unsafe Sex | 1 | 2008 | 19 | 0.070 |
Why?
|
| Organ Size | 1 | 2008 | 16 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 25 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2007 | 22 | 0.060 |
Why?
|
| Self Care | 2 | 2005 | 139 | 0.060 |
Why?
|
| Sick Role | 1 | 2006 | 9 | 0.060 |
Why?
|
| Self Concept | 1 | 2006 | 36 | 0.060 |
Why?
|
| Health Status | 3 | 2006 | 256 | 0.060 |
Why?
|
| Hypersensitivity | 1 | 2005 | 20 | 0.060 |
Why?
|
| Cesarean Section | 1 | 2005 | 34 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2005 | 60 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2004 | 294 | 0.060 |
Why?
|
| Social Support | 1 | 2006 | 195 | 0.060 |
Why?
|
| Occupational Diseases | 1 | 2004 | 33 | 0.050 |
Why?
|
| Health Services | 2 | 2004 | 100 | 0.050 |
Why?
|
| Adolescent Behavior | 2 | 2014 | 118 | 0.050 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2002 | 85 | 0.040 |
Why?
|
| Mood Disorders | 1 | 2001 | 15 | 0.040 |
Why?
|
| Health Equity | 1 | 2021 | 26 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2007 | 346 | 0.040 |
Why?
|
| Reinforcement, Social | 1 | 2001 | 1 | 0.040 |
Why?
|
| Cognitive Therapy | 1 | 2001 | 1 | 0.040 |
Why?
|
| Community Mental Health Services | 1 | 2001 | 30 | 0.040 |
Why?
|
| Aftercare | 1 | 2001 | 46 | 0.040 |
Why?
|
| Naloxone | 1 | 2020 | 19 | 0.040 |
Why?
|
| Food Analysis | 1 | 1999 | 5 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1999 | 14 | 0.040 |
Why?
|
| Parents | 1 | 2002 | 298 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2005 | 100 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 325 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2002 | 353 | 0.030 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 1998 | 1 | 0.030 |
Why?
|
| Mediastinoscopy | 1 | 1998 | 5 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2005 | 410 | 0.030 |
Why?
|
| Bias | 1 | 2017 | 90 | 0.030 |
Why?
|
| Colorado | 2 | 2007 | 171 | 0.030 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2016 | 10 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2016 | 25 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2016 | 23 | 0.030 |
Why?
|
| DNA | 1 | 2016 | 25 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 41 | 0.030 |
Why?
|
| Sigmoidoscopy | 1 | 2016 | 61 | 0.030 |
Why?
|
| Data Accuracy | 1 | 2016 | 26 | 0.030 |
Why?
|
| Health Surveys | 2 | 2006 | 226 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 171 | 0.030 |
Why?
|
| White Coat Hypertension | 1 | 2015 | 3 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 14 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 30 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 21 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2014 | 11 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2010 | 278 | 0.030 |
Why?
|
| Sex Factors | 2 | 2006 | 560 | 0.030 |
Why?
|
| Dopamine Agents | 1 | 2013 | 2 | 0.030 |
Why?
|
| Memantine | 1 | 2013 | 3 | 0.030 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2013 | 4 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2013 | 11 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2013 | 33 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2014 | 92 | 0.020 |
Why?
|
| Bupropion | 1 | 2013 | 9 | 0.020 |
Why?
|
| Algorithms | 2 | 2005 | 210 | 0.020 |
Why?
|
| Comorbidity | 2 | 2007 | 516 | 0.020 |
Why?
|
| Life Style | 1 | 2014 | 305 | 0.020 |
Why?
|
| Premature Birth | 1 | 2014 | 133 | 0.020 |
Why?
|
| Caregivers | 1 | 2013 | 132 | 0.020 |
Why?
|
| Decision Making | 1 | 2013 | 164 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2011 | 22 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2011 | 16 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2005 | 229 | 0.020 |
Why?
|
| Psychotherapy, Group | 2 | 2001 | 20 | 0.020 |
Why?
|
| Calcium Compounds | 1 | 2010 | 3 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2010 | 10 | 0.020 |
Why?
|
| Washington | 2 | 2002 | 376 | 0.020 |
Why?
|
| Smoking | 1 | 2013 | 373 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 41 | 0.020 |
Why?
|
| Lipids | 1 | 2010 | 66 | 0.020 |
Why?
|
| Prevalence | 2 | 2004 | 785 | 0.020 |
Why?
|
| Cyclobutanes | 1 | 2010 | 5 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 55 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2010 | 71 | 0.020 |
Why?
|
| Adiposity | 1 | 2010 | 69 | 0.020 |
Why?
|
| Vitamin D | 1 | 2010 | 75 | 0.020 |
Why?
|
| Appetite Depressants | 1 | 2010 | 16 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 161 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2009 | 58 | 0.020 |
Why?
|
| Psychometrics | 1 | 2007 | 114 | 0.020 |
Why?
|
| Demography | 1 | 2007 | 89 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 81 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2007 | 112 | 0.020 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2006 | 13 | 0.020 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2005 | 2 | 0.010 |
Why?
|
| Respiratory System Agents | 1 | 2005 | 2 | 0.010 |
Why?
|
| Birth Order | 1 | 2005 | 4 | 0.010 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2005 | 3 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 13 | 0.010 |
Why?
|
| Medical Audit | 1 | 2005 | 31 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2006 | 211 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 2005 | 8 | 0.010 |
Why?
|
| Maternal Age | 1 | 2005 | 73 | 0.010 |
Why?
|
| Cues | 1 | 2005 | 10 | 0.010 |
Why?
|
| Dermatitis, Atopic | 1 | 2005 | 18 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 149 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2005 | 305 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 1233 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2005 | 192 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 352 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2004 | 164 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2004 | 68 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 221 | 0.010 |
Why?
|
| Drug Prescriptions | 1 | 2004 | 137 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 2002 | 32 | 0.010 |
Why?
|
| Registries | 1 | 2004 | 449 | 0.010 |
Why?
|
| Personality Assessment | 1 | 2001 | 10 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 41 | 0.010 |
Why?
|
| Psychotherapy, Brief | 1 | 2001 | 19 | 0.010 |
Why?
|
| Patient Selection | 1 | 2002 | 175 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 261 | 0.010 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2001 | 17 | 0.010 |
Why?
|
| Health Policy | 1 | 2001 | 101 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2001 | 117 | 0.010 |
Why?
|
| Child Health Services | 1 | 2001 | 104 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1999 | 76 | 0.010 |
Why?
|
| Research Design | 1 | 2001 | 319 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2005 | 2463 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2001 | 248 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1998 | 4 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1998 | 5 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 52 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1998 | 26 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 1887 | 0.010 |
Why?
|
| Hospitalization | 1 | 2002 | 816 | 0.010 |
Why?
|
Concepts
(274)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->